The global pandemic crisis affected almost every society and economy, challenged almost every health system worldwide. Above all, governments and non-governmental organizations had to fight the misinformation and conspiracy theories placed by the social and mass media. All of this had a profound impact on the public in terms of vaccine safety and the advantages of vitamin use in fighting the virus. This fear has opened doors to alternative medicines such as supplements (vitamins, minerals, herbal products, oils) that may have profound effects on the immune system. To determine the pattern of use of supplements during the pandemic in healthy individuals who tested negative for SARS-CoV-2. The 33 healthy individuals tested negative for SARS-CoV-2 in the pandemic period were included (Group 1). Total antioxidant power, iron-reducing (PAT), and plasma peroxides (d-ROMs) were measured using FRAS5 analytical photometric system and are reported in equivalents of ascorbic acid and H2O2, respectively. The oxidative stress index (OSI) was automatically calculated by the software. The obtained values were compared with 30 healthy individuals analyzed prior to the pandemic (Group 2). The mean values for oxidative stress parameters in Group 1 vs Group 2 were: d-ROMs 418 vs 266 U. Carr, PAT 3862 vs 2554 U. Carr, and OSI 111 vs 36. In all comparisons, a statistically significant difference was obtained (p<0.05, t-test). Individuals belonging to Group 1 had reported that they have consumed daily doses of Zinc (30 mg), Vitamin C (at least 1000 mg) and Vitamin D (at least 2000 IU) in a period of >1 month. Several of them have also used Isoprinosine, magnesium, and selenium. Uncontrolled intake of supplements can have a profound effect on the pro- and antioxidant balance resulting in interruption of the phycological balance and leading to increased oxidative stress index in otherwise healthy individuals. 

Imatinib, a tyrosine kinase inhibitor (TKI) is used as a standard treatment in chronic myeloid leukemia (CML) patients. Increased levels of BCR-ABL1 expression in CML cells are associated with oxidative stress induction due to overproduction of reactive oxygen species (ROS) or by deficient antioxidant system, disease progression, and imatinib resistance. Current scientific research confirms that oxidative stress is involved in CML pathogenesis and response to TKI treatment. Moreover, recent findings suggest that the antioxidant properties of some natural compounds can provide benefits to patients with CML. To determine the effect of adjuvant treatment with polyphenols on the oxidative stress markers in imatinib-treated CML patients. 40 CML patients at the University Clinic of Hematology, Skopje, who received imatinib longer than 1 month were included in the study. 20 patients were additionally treated with Aronia melanocarpa extract and 20 patients received only imatinib (control group). Besides the regular clinical laboratory analysis for these patients, total antioxidant power (PAT) and plasma peroxides (d-ROMs) were measured at initial visit and after 21 and 42 days of treatment using FRAS5 analytical photometric system and the oxidative stress index (OSI) was automatically calculated. Oxidative stress parameters (d-ROM and OSI) were significantly higher at initial visit in both groups. In group of patients who received adjuvant polyphenols values for d-ROM and OSI were significantly lower after 21 and 42 days of treatment (p<0.05). Also, total antioxidant capacity (PAT) was significantly higher after 21 and 42 days of treatment initiation in comparison with the pretreatment values. In the control group, no significant differences were obtained between investigated parameters at any time of measurement. Adjuvant treatment with Aronia melanocarpa extract after 21 and 42 days led to significant reduction of oxidative stress parameters in patients with CML treated with imatinib.